Pay in 4 interest-free payments of $5.77 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
2022;79(17):e263421
When Cost Plus offers imatinib for $13.40 per 30-day supply and demonstrates patient and payer demand, it provides market intelligence that a generic manufacturer might not have been able to generate independently
Hendershot emphasized that the participants were not actively trying to cut back on drinking or become abstinent, making the drugs impact particularly interesting
It focuses on the SURPASS and SURMOUNT clinical trial programs, presently the best evaluations of Tirzepatide's clinical efficacy
.png.jpg)
US$ 29.60
US$ 26.73
US$ 28.21
US$ 29.34
US$ 22.40
